Research Program Materials Clause Samples

The 'Research Program Materials' clause defines the ownership, use, and handling of materials, data, or information generated or used during a research program. It typically specifies which party retains rights to physical samples, data sets, or proprietary information, and may outline procedures for sharing, returning, or destroying such materials at the end of the project. This clause ensures clarity regarding intellectual property and material rights, preventing disputes over access and use of research outputs.
Research Program Materials. The parties contemplate that each of them will make compounds and/or biological materials available for purposes of the Research Program and that additional compounds may be invented and/or synthesized in the course of the Research Program. In respect of such compounds and/or biological materials, the parties agree as follows: 2.11.1 Compounds or biological materials transmitted by one Party to another pursuant to this Agreement (i) shall be distributed only to the employees of the receiving Party who have a need to receive them to carry out the terms of this Agreement, (ii) shall be used solely for the purposes expressly set forth in this Agreement (iii) subject to 2.11.2, shall be returned promptly to the transmitting Party upon such Party's request and (iv) shall not be disclosed or distributed to any third party without the prior written consent of the Party transmitting such compounds or biological material. 2.11.2 Compounds that are used in the Research Program and are determined not to be Lead Candidates shall be returned to the Party which made such compound available. Ownership of Compounds shall be determined in accordance with the terms of this Agreement, and all such Compounds that are determined not to be Lead Candidates shall revert to the Party or Parties that own(s) such Compounds. Any such Compound which is returned to a Party pursuant to this Section 2.11.2 may not be developed, made, used or sold by such Party, its Affiliates or licensees in the Expanded Field prior to the First Commercial Sale in a Major Market Country of a Licensed Product developed pursuant to this Agreement. Compounds that are determined to be Lead Candidates shall remain available to the Parties for the purposes of the Research Program and shall be subject to the terms of this Agreement.
Research Program Materials. During the term of this Agreement, upon request by either Party, the Party to whom the request is made will promptly provide to the other Party such quantities of Research Program Materials as shall be reasonably available in excess of its own needs for such other Party to carry out its respective responsibilities under this Agreement. Subject to the licenses set forth in Article Three, each Party may use the Research Program Materials created or developed by such Party for any purpose.
Research Program Materials. The Parties acknowledge and agree that Exhibit D has been agreed by the Parties as of the Second Restatement Effective Date, and that materials that are different than or in addition to the materials set forth on Exhibit D may result from a Research Program. Upon the reasonable request of Spyre, the Parties shall update Exhibit D to reflect, as applicable, the general list of tangible materials, including samples, reagents, nucleic acids and Antibodies, resulting from all Research Programs, or to add a separate list of tangible materials that are customized for and shall apply specifically with respect to a particular Research Program.

Related to Research Program Materials

  • Research Program The term “

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Project The findings of any research project, which would change the provisions of this Agreement will not be implemented until such changes are negotiated and agreed to by the parties.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.